GENFIT (GNFT)
(Delayed Data from NSDQ)
$4.52 USD
+0.37 (8.92%)
Updated Jul 25, 2024 03:59 PM ET
After-Market: $4.51 -0.01 (-0.22%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
GENFIT S.A. Unsponsored ADR [GNFT]
Reports for Purchase
Showing records 101 - 117 ( 117 total )
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Join Our Call with Dr. Ratziu on July 24 to Predict RESOLVE-IT Readout
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Terns Deal Offers Glimpse of Global Ambitions and Focus on Combination NASH Therapy
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
NASH Weekly: Let''s Not Punish the PPAR Agonists
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
NASH Combo Program Launched; POC Trial to Start in 2H19; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Healthcare -Recap of 34 Notes From Our Coverage of EASL 2019 and AASLD
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
DSMB Recommends Elafibranor Continue Pivotal Phase 3 RESOLVE-IT Trial Without Changes; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
PBC Treatment Gaps Leave Opportunity for Growth
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
Company: GENFIT S.A. Unsponsored ADR
Industry: Medical - Biomedical and Genetics
With Nasdaq Listing Complete, Focus Sharpens on NASH and PBC; Adjust PT to $72
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E